FAQ

Ketamine developed a reputation as a drug of abuse and is also known as Vitamin K, Special K, Kit Kat or an animal tranquilizer. Addiction has not been described when following the low-dose infusion treatment schedule Klarity uses.
Ketamine has been used extensively in the hospital setting as an anesthetic agent since being FDA-approved in the mid-1960’s and has a proven track record of safety and good patient tolerance.

There is a movement to push the FDA for approval for the treatment of depression. However, without adequate backing, it will be difficult to finance the trials and bureaucratic navigation required to gain FDA approval for treatment of depression and chronic pain.
Alternative formulations such as nasal sprays or sublingual tabs have been developed but are far more costly and lack the effectiveness of low-dose ketamine infusion therapy.
There are also past and ongoing studies to demonstrate the effectiveness of ketamine for drug and alcohol addiction. To our knowledge, there is no current push for FDA approval for ketamine for the treatment of drug and alcohol addiction.

Chronic use of benzodiazepines (e.g. Ativan and Xanax) and Lamictal (Lamotrigine) may render ketamine therapy less effective, and we may recommend those medications be stopped or dosages significantly reduced at least 5-14 days before treatment. Patients on MAOI’s should not take ketamine.
Consult with your prescribing doctor prior to stopping any medication.

As anesthesiologists, we are intimately familiar with the usage of ketamine in the operating room environment. We are more comfortable using ketamine at the higher doses that help us achieve our exceptional success rates.
Anesthesiologists are also trained in the handling and treatment of potential emergent situations in the unlikely event that they occur.

The occasional side effects that we see from low dose ketamine treatments usually resolve shortly after treatment. We may use supplemental medications to treat nausea, anxiety, hallucinations, and/or blood pressure changes.

Be careful of other products marketing themselves as NAD. NAD+, NADH and NR (Nicotinamide Riboside) are not the same. Although NAD+ plays a role in the same pathway as NADH and NR, there are certain NAD+ consuming reactions where only NAD+ can be utilized. In these reactions, NADH and NR are not effective.
While NADH and NR are less expensive than NAD+, the positive effects are not nearly as potent as NAD+. BR+NAD and our REAL NAD+ tablets are the purest forms of NAD+ available.

More than 82 percent of our patients who complete the series of six treatments have a significant to near-total relief of systems. Success is defined as a reduction in depression scores and/or perceived reduction of symptoms. Our success rates for Drug & Alcohol addiction are even higher.

Your safety and treatment success is of utmost importance to Klarity Life. We want to ensure that you are the right candidate for ketamine and NAD+ therapy with ongoing mental health support. This ensures that we can optimize our chances of success in treating your conditions.
To accept every patient requesting treatment if we deem them to have a low probability of success would be unethical.

Feel free to share the links and information provided on our website to others for education on this groundbreaking treatment option. We would be happy to speak to them also.
Prior to treatment, we will discuss with them our participation in your care and ensure that your diagnosis will receive the appropriate course of treatment.